sulfasalazine has been researched along with Infectious Diseases in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le Roux-Villet, C | 1 |
| Prost-Squarcioni, C | 1 |
| Alexandre, M | 1 |
| Caux, F | 1 |
| Pascal, F | 1 |
| Doan, S | 1 |
| Brette, MD | 1 |
| Soued, I | 1 |
| Gabison, É | 1 |
| Aucouturier, F | 1 |
| Letestu, R | 1 |
| Laroche, L | 1 |
| Bachelez, H | 1 |
1 other study available for sulfasalazine and Infectious Diseases
| Article | Year |
|---|---|
Rituximab for patients with refractory mucous membrane pemphigoid.
Topics: Adolescent; Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Deriv | 2011 |